Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • ASSOCIATION BETWEEN HEPARIN DOSE AND 6-WEEKS MORTALITY IN PATIENTS WITH COVID-19

    Claire Coutureau, Philippe Nguyen, Maxime Hentzien, Peter Joe Noujaim, Sarah Zerbib, Damien Jolly, Lukshe Kanagaratnam
    e2022036
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.036
    1114
    PDF: 623
    HTML: 420
  • Parasitic hypereosinophilia in childhood: a diagnostic challenge

    Roberto Antonucci, Nadia Vacca, Giulia Boz, Cristian Locci, Rosanna Mannazzu, Claudio Cherchi, Giacomo Lai, Claudio Fozza
    e2018034
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.034
    2886
    PDF: 908
    HTML: 407
    Figure 1: 257
  • HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA

    Giuseppe Avvisati
    e2011064
    2011-12-19
    https://doi.org/10.4084/mjhid.2011.064
    13439
    PDF: 1077
    HTML: 7341
  • Successful management of pregnancy and hepatic toxicity in a CML female patient treated with nilotinib : a case report and a review

    Domenico Santorsola, Elisabetta Abruzzese
    e2015020
    2015-02-12
    https://doi.org/10.4084/mjhid.2015.020
    2197
    PDF: 1311
    HTML: 1681
  • CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA

    Livio Pagano, Morena Caira, Caterina Giovanna Valentini, Luana Fianchi
    e2009030
    https://doi.org/10.4084/mjhid.2009.030
    1522
    PDF: 669
    HTML: 4208
  • IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW

    Tomasz Sacha
    e2014007
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.007
    5260
    PDF: 3046
    HTML: 2389
  • DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE

    Ibrahim C. Haznedaroglu
    e2015014
    2015-12-02
    https://doi.org/10.4084/mjhid.2015.014
    277962
    PDF: 1926
    HTML: 3920
  • OUTCOME AND TOXICITY PATTERNS IN CHILDREN AND ADOLESCENTS WITH NON-HODGKIN LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

    Paola Angelini, Laura Rodriguez, Mohammed Zolaly, Ahmed Naqvi, Sheila Weitzman, oussama Abla, Angela Punnett
    e2018020
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.020
    3120
    PDF: 940
    HTML: 442
  • ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS

    Lourdes Vazquez
    e2016040
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.040
    4524
    PDF: 1489
    HTML: 2216
  • SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival

    Stergios Intzes, Marianthi Symeonidou, Konstantinos Zagoridis, Aikaterini Pentidou, Spanoudakis Emmanouil
    e2021006
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.006
    2377
    PDF: 953
    HTML: 391
  • VACCINATION FOLLOWING LEUKEMIA TREATMENT: VIRAL VACCINE RESPONSES IN SURVIVORS OF ACUTE LYMPHOBLASTIC LEUKEMIA

    Elif Kilic Konte, Ayca Koca Yozgat, Aysun Kara Uzun, Bahar Cuhaci Cakir, Nese Yarali
    e2025049
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.049
    1122
    PDF: 662
    HTML: 92
  • THE CHALLENGE OF AML IN OLDER PATIENTS

    Alan K Burnett
    e2013038
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.038
    2516
    PDF: 1098
    HTML: 2251
  • PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations

    Michele Bibas
    e2024007
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.007
    3886
    PDF: 2682
    HTML: 1722
  • NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa

    Alessandro Matte, Filippo Mazzi, Enrica Federti, Oliviero Olivieri, Lucia De Franceschi
    e2019002
    2019-01-01
    https://doi.org/10.4084/mjhid.2019.002
    7309
    PDF: 3882
    HTML: 865
  • ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

    Federico Lussana, Alessandro Rambaldi
    e2014065
    2014-10-20
    https://doi.org/10.4084/mjhid.2014.065
    3098
    PDF: 1374
    HTML: 2856
    Figure 1: 239
  • PREVENTION AND TREATMENT OF HEPATITIS VIRUS INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

    Suparno Chakrabarti, Somnath Mukherjee
    e2009017
    2009-12-10
    https://doi.org/10.4084/mjhid.2009.017
    980
    PDF: 616
    HTML: 2490
  • BRUTON’S TYROSINE KINASE (BTK) MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A CLINICAL VIEW.

    Stefano Molica
    e2025053
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.053
    1989
    PDF: 1090
    HTML: 486
  • PATHOBIOLOGY AND TREATMENT OF HEPATITIS VIRUS-RELATED THROMBOCYTOPENIA

    Roberto Stasi, Lian Wea Chia, Pallavi Kalkur, Robert Lown, Muriel S. Shannon
    e2009023
    https://doi.org/10.4084/mjhid.2009.023
    1041
    PDF: 649
    HTML: 1486
  • THE ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.

    Sumeyye Kazancioglu, Ebru Ayöztürk, Seval Izdes, Rahmet Guner
    e2026050
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.050
    308
    PDF: 266
    HTML: 135
  • IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis

    Derya Alabaz, Fadime Eroğlu, Hüseyin Elçi, Ümmühan Çay
    e2022053
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.053
    1250
    PDF: 804
    HTML: 295
  • Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance

    Holly Lee, Peter Duggan, Ernesta Paola Neri, Jason Tay, Victor Jimenez Zepeda
    e2019007
    2019-01-01
    https://doi.org/10.4084/mjhid.2019.007
    2487
    PDF: 1248
    HTML: 440
  • Morphologic leukemia-free state after venetoclax-based therapy in acute myeloid leukemia is associated with high relapse despite preserved short-term survival

    Kenta Motegi
    e2026048
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.048
    492
    PDF: 448
    HTML: 299
  • Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy

    Claudio Ucciferri, Alessandro Occhionero, Jacopo Vecchiet, Katia Falasca
    e2018069
    2018-10-29
    https://doi.org/10.4084/mjhid.2018.069
    1751
    PDF: 1060
    HTML: 246
  • Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment

    Katia Paciaroni, Gioia De Angelis, Cristiano Gallucci, Cecilia Alfieri, Michela Ribersani, Andrea Roveda, Antonella Isgrò, Marco Marziali, Ivan Pietro Aloi, Alessandro Inserra, Javid Gaziev, Pietro Sodani, Guido Lucarelli
    e2015006
    2015-08-01
    https://doi.org/10.4084/mjhid.2015.006
    2147
    PDF: 1221
    HTML: 1951
    Lung computed tomography CT scan image: 257
  • SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY

    Francesco Ricci
    e2012048
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.048
    6479
    PDF: 3535
    HTML: 9080
    Figure Malaria Ricci: 299
  • INVASIVE CANDIDA INFECTIONS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES AND HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: CURRENT EPIDEMIOLOGY AND THERAPEUTIC OPTIONS.

    Corrado Girmenia, Erica Finolezzi, Vincenzo Federico
    e2011013
    2011-03-14
    https://doi.org/10.4084/mjhid.2011.013
    2588
    PDF: 1089
    HTML: 1882
  • INFECTIOUS RISKS AND COMPLICATIONS IN ADULT LEUKEMIC PATIENTS RECEIVING BLINATUMOMAB

    Wonhee So, Shuchi Pandya, Rod Quilitz, John Greene
    e2018029
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.029
    3211
    PDF: 1205
    HTML: 396
  • DIRECT ORAL ANTICOAGULANTS IN PATIENTS AFFECTED BY MAJOR CONGENITAL THROMBOPHILIA

    alessandra serrao, benedetta lucani, davide mansour, antonietta ferretti, erminia baldacci, cristina santoro, robin foà, antonio chistolini
    e2019044
    2019-06-25
    https://doi.org/10.4084/mjhid.2019.044
    2101
    PDF: 1601
    HTML: 508
  • WHAT ARE FUNGAL INFECTIONS?

    Ben E de Pauw
    e2011001
    2011-01-03
    https://doi.org/10.4084/mjhid.2011.001
    4475
    PDF: 2556
    HTML: 27723
    de Pauw: 312
  • CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA

    Alessandro Bartoloni, Lorenzo Zammarchi
    e2012026
    2012-05-04
    https://doi.org/10.4084/mjhid.2012.026
    8651
    PDF: 4651
    HTML: 7633
  • NOVEL DRUGS IN FOLLICULAR LYMPHOMA

    Giuseppe Rossi, Antonella Anastasia
    e2016061
    2016-11-01
    https://doi.org/10.4084/mjhid.2016.061
    6028
    PDF: 1638
    HTML: 1690
    Untitled: 296
  • A novel germline JAK2 splice-site variant causing exon 10 skipping in a patient with clinically diagnosed essential thrombocythemia and early-onset tophaceous gout: a case report

    Xun Zhu, Yaomei Long, Liye Zhong, Xiuli Wu, Ling Xu, Jie Wu
    e2026083
    2026-10-31
    https://doi.org/10.4084/MJHID.2026.083
    97
    PDF: 39
    Suppl. Files: 30
    Html: 38
    Html Suppl. Files: 13
  • FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells

    Eugenio Galli, Filippo Frioni, Tanja Malara, Enrico Attardi, Silvia Bellesi, Stefan Hohaus, Simona Sica, Federica Sorà, Patrizia Chiusolo
    e2024029
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.029
    1160
    PDF: 1325
    HTML: 145
  • Evaluating the use of meropenem in hematologic patients with febrile neutropenia A retrospective observational single-cohort study

    R.A. Stuurman, E. Jong, P.C.R. Godschalk, M.F. Corsten, J.E. Nagtegaal
    e2023067
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.067
    1419
    PDF: 581
    HTML: 167
  • MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA

    Melanie Joannides, Ashley N Mays, Anita R Mistry, Syed Khizer Hasan, Andreas Reiter, Joseph L Wiemels, Carolyn A Felix, Francesco Lo-Coco, Neil Osheroff, Ellen Solomon, David Grimwade
    e2011045
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.045
    3335
    PDF: 990
    HTML: 6637
    Untitled: 301
    Untitled: 259
    Untitled: 281
    Untitled: 285
  • OUTCOME OF FRONTLINE TREATMENT WITH “GENERIC” IMATINIB IN ADULT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ALGERIAN POPULATION: A MULTICENTER STUDY

    Mohamed Amine BEKADJA
    e2017062
    2017-10-25
    https://doi.org/10.4084/mjhid.2017.062
    3078
    PDF: 823
    HTML: 953
  • CLINICAL SIGNS AND TREATMENT OF NEW-ONSET BONE MARROW FAILURE ASSOCIATED SARS-COV-2 INFECTION IN CHILDREN : A SINGLE INSTITUTION PROSPECTIVE COHORT STUD

    Mervat A M youssef, Ebtisam Shawky hmed, Dalia Tarik Kamal, khalid Elsayh,, Mai A Abdelfatta, Hyam Hassan Mahran Mahran, Mostafa M Embaby
    e2024034
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.034
    1370
    PDF: 1454
    HTML: 147
  • CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY

    Maria Ilaria Del Principe, Luca Maurillo, Francesco Buccisano, Giuseppe Sconocchia, Mariagiovanna Cefalo, Giovanna De Santis, Ambra Di Veroli, Concetta Ditto, Daniela Nasso, Massimiliano Postorino, Marco Refrigeri, Cristina Attrotto, Giovanni Del Poeta, Sergio Amadori, Adriano Venditti
    e2014075
    2014-11-01
    https://doi.org/10.4084/mjhid.2014.075
    4520
    PDF: 2067
    HTML: 5577
    Table 1: 319
  • AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging

    Dr.Sophia Delicou, Dr.Ioannis Ilias, Dr.Athanasia Kapota, Dr.Elena Papatheodorou, Dr.Maria Moraki, Dr.Aikaterini Xydaki, Dr.Alexandra Mika, Dr.Panagiota Giannou, Dr.Irene Kouroukli, Dr.Theodoros Aforozis, Dr.Myrto Palkopoulou, Dr.Christos Savvidis, Dr.Iliana Mani, Prof.Constantina Aggeli, Prof. John Koskinas
    e2026039
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.039
    691
    PDF: 679
    Suppl. Files: 99
    HTML: 180
  • HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION

    Francesco Lo-Coco, Laura Cicconi
    e2011067
    2011-12-21
    https://doi.org/10.4084/mjhid.2011.067
    3418
    PDF: 1217
    HTML: 2036
  • CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma

    Ugo Testa, Francesco D'Alò, Elvira Pelosi, Germana Castelli, Giuseppe Leone
    e2024012
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.012
    2559
    PDF: 1993
    HTML: 196
  • Bone marrow involvement in a patient with alpha heavy chain disease:Response to tetracycline treatment

    Zahit Bolaman, Irfan Yavasoglu, Gokhan Sargin, Gurhan Kadikoylu, Firuzan Kacar Doger
    e2012034
    2012-05-07
    https://doi.org/10.4084/mjhid.2012.034
    1391
    PDF: 1107
    HTML: 3434
  • THERAPEUTIC OPTIONS FOR PATIENTS WHO ARE NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY

    Elihu Estey
    e2013050
    2013-07-12
    https://doi.org/10.4084/mjhid.2013.050
    2338
    PDF: 852
    HTML: 1654
  • LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE

    Massimo Breccia, Corrado Girmenia, Roberto Latagliata, Giuseppina Loglisci, Michelina Santopietro, Vincenzo Federico, Luigi Petrucci, Alessandra Serrao, Adriano Salaroli, Giuliana Alimena
    e2011021
    2011-05-16
    https://doi.org/10.4084/mjhid.2011.021
    1862
    PDF: 887
    HTML: 937
    jdoe, table 2 infections CML .doc: 263
    jdoe, table 1 infections CML .doc: 238
  • AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA: AN EFFECTIVE AND MANAGEABLE APPROACH.

    Pasquale Niscola
    e2014020
    2014-02-16
    https://doi.org/10.4084/mjhid.2014.020
    3196
    PDF: 987
    HTML: 2812
  • ROLE OF HEMATOLOGICAL PARAMETERS AS AN INDICATOR OF ACUTE MALARIAL INFECTION IN UTTARAKHAND STATE OF INDIA

    Smita Chandra, Harish Chandra
    e2013009
    2013-01-02
    https://doi.org/10.4084/mjhid.2013.009
    1937
    PDF: 885
    HTML: 5976
  • Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited

    IOANNIS KOTSIANIDIS
    e2019045
    2019-06-25
    https://doi.org/10.4084/mjhid.2019.045
    1340
    PDF: 969
    HTML: 379
  • Luspatercept Treatment in a β-Thalassemia Patient with Pulmonary Arterial Hypertension: A Case Report

    beibei yang, dongmei liu, changyu yang, Yali zhou, Guiping Liao, jian huang, Yingying Li, yinjiang tang, xiaolin yin
    e2025059
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.059
    1339
    PDF: 698
    Html: 212
  • HEMATOPOIETIC STEM CELL TRANSPLANTATION IN EGYPT CHALLENGES AND OPPORTUNITIES

    Hossam Kamel Mahmoud, Gamaleldin Mohamed Fathy, Alaa Elhaddad, Omar Abdelrahman Fahmy, Mohamed Abdelmooti, Raafat Abdelfattah, Mahmoud Tarek Sayed Ahmed Bokhary
    e2020023
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.023
    2082
    PDF: 1092
    HTML: 934
  • MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus

    Emanuele Focà, Silvia Odolini, Nigritella Brianese, Gianpiero Carosi
    e2012032
    2012-05-07
    https://doi.org/10.4084/mjhid.2012.032
    2892
    PDF: 1135
    HTML: 2416
201 - 250 of 500 items << < 1 2 3 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.